-
Arcturus Therapeutics (NASDAQ:ARCT) Price Target Lowered to $68.00 at Canaccord Genuity Group
Source: Buzz FX / 10 Mar 2025 10:58:16 America/Chicago
Arcturus Therapeutics (NASDAQ:ARCT) Price Target Lowered to $68.00 at Canaccord Genuity Group Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads Arcturus Therapeutics ( NASDAQ:ARCT - Get Free Report ) had its pr
Read more...